Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00149552 · ClinicalTrials.gov registry record · NA
Zinc Therapy in HIV Infected Individuals Who Abuse Drugs
A NA study, sponsored by Florida International University.
- Completed
- Registry status
- NA
- Development phase
- 231
- Enrollment target
NCT00149552: Completed NA study, sponsored by Florida International University.
NCT00149552 is a NA study that has completed, run by Florida International University. The registered enrollment target is 231 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00149552, a NA study, has completed, sponsored by Florida International University.
- COMPLETED
- Registry status
- NA
- Development phase
- 231 participants
- Enrollment target
Study Summary
Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.
Primary Outcome
CD4 cell count \<200 cells/uL
Interventions
- DIETARY_SUPPLEMENT zinc
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 231 participants |
| Start Date | 2001-06 |
| Est. Completion | 2007-01 |
| Phase | NA |
What the finished NCT00149552 record still lists
NCT00149552 is an interventional study that assigns participants to a tested intervention. The registered 231 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 1 intervention - of which zinc is the first listed.
NCT00149552 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00149552 about?
NCT00149552 is a clinical study titled "Zinc Therapy in HIV Infected Individuals Who Abuse Drugs". Zinc deficiency is prevalent in HIV infected individuals who abuse drugs. The purpose of this study is to determine if zinc therapy will prevent immune failure in HIV infected individuals who abuse drugs and have low plasma zinc levels.
What is the current status of trial NCT00149552?
This trial is currently completed. It is a NA study. The enrollment target is 231 participants. The study started on 2001-06. Estimated completion is 2007-01.
What interventions are being tested in trial NCT00149552?
The interventions under investigation include: zinc (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00149552?
This trial is sponsored by Florida International University, which has 89 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00149552's enrollment target sits among peer trials
231 465th of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04077099 · 231 participants · Phase 1
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
- NCT05019495 · 231 participants · NA
Optimizing Tobacco Treatment Delivery for People Living With HIV
- NCT06023589 · 231 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
- NCT06734351 · 231 participants · Phase 3
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia